GlobalData on MSN
Parkinson’s research reaches “pivotal” stage, but barriers remain
Funding and clinical trial-based barriers must be addressed to ensure success on the path to developing a DMT for Parkinson’s.
Health systems and their technology vendors can work together to modernize clinical process maps using artificial intelligence – transforming them from static reference documents into living guidance ...
Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
TEMECULA, CALIFORNIA , UNITED STATES, February 10, 2026 /EINPresswire.com/ — Dr. Dayan Goodenowe, author of Breaking Alzheimer’s, will present a formal FDA ...
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results